This inventor holds 3 USPTO granted patents. Top assignees: University of Missouri, The University of North Carolina at Chapel Hill. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 900 
2 out of 1,330 
Years Active: 1997
Title: The Innovative Contributions of John T. Turner
Introduction
John T. Turner, an accomplished inventor based in Ashland, MO, has made significant contributions to the field of cellular biology through his innovative research and patent filings. With a total of three patents to his name, he has focused on advancements in understanding and manipulating receptor activity, particularly the P.sub.2U receptor.
Latest Patents
Turner's most notable patents include methods aimed at inhibiting cell growth through the P.sub.2U receptor. His innovations encompass isolated DNAs encoding the human P.sub.2U receptor, along with vectors and host cells designed for various applications in research and therapy. Additionally, he has developed methods for detecting compounds that bind to the P.sub.2U receptor, allowing for a deeper understanding of receptor interactions and their implications in cellular processes. These host cells are engineered to be nearly free of endogenous P.sub.2U receptor expression while expressing a heterologous receptor, facilitating experimental efficacy.
Career Highlights
Throughout his career, Turner has worked at prominent research institutions, notably the University of Missouri and the University of North Carolina at Chapel Hill. His roles in these institutions have allowed him to collaborate with a range of scientists and researchers to advance the understanding of cell signaling and receptor activity, which are vital for numerous therapeutic strategies.
Collaborations
Turner has collaborated with esteemed colleagues, including Richard C. Boucher and Gary A. Weisman. These partnerships have enriched his research and have fostered innovative approaches to studying the P.sub.2U receptor and its biological significance.
Conclusion
John T. Turner's contributions through his patents and collaborative projects reflect a deep commitment to innovation in the field of cellular biology. His research not only enhances our understanding of critical cellular mechanisms but also paves the way for potential therapeutic applications targeting cell growth and receptor interactions. As his work continues to evolve, it will undoubtedly influence future discoveries in this dynamic field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile